These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2875644)

  • 1. Inhibition of platelet aggregation by isosorbide dinitrate.
    Ahlner J; Andersson R; Axelsson K; Wallentin L
    Am J Cardiol; 1986 Sep; 58(7):665. PubMed ID: 2875644
    [No Abstract]   [Full Text] [Related]  

  • 2. Impairment of platelet behaviour by isosorbide dinitrate.
    Dutrillaux F; Lecompte T; Samama M
    Thromb Haemost; 1989 Feb; 61(1):152-3. PubMed ID: 2665166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2].
    De Caterina R; Crea F; Giannessi D; Bernini W; Gazzetti P; Chierchia S; Distante A; L'Abbate A
    Cardiologia; 1982; 27(3):315-7. PubMed ID: 6892461
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isosorbide dinitrate inhibits in vitro platelet aggregation at submicromolar concentrations].
    Gachet C; Guillou J; Moog S; Cazenave JP
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():61-5. PubMed ID: 1326933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of isosorbide dinitrate on platelet aggregation and production of thromboxane B2].
    De Caterina R; Crea F; Giannessi D; Bernini W; Gazzetti P; Chierchia S; Distante A; L'Abbate A
    Cardiologia; 1982; 27(3):315-7. PubMed ID: 6927441
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease.
    Sinzinger H; Fitscha P; O'Grady J; Rauscha F; Rogatti W; Vane JR
    Lancet; 1990 Mar; 335(8690):627-8. PubMed ID: 1969017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
    De Caterina R; Giannessi D; Bernini W; Mazzone A
    Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evidence of an endothelial cell-dependent antiplatelet activity for isosorbide dinitrate, but not for its 2- and 5-mononitrate metabolites.
    Rolland PH; Berenger FP; Cano JP
    J Pharmacol Exp Ther; 1987 Jan; 240(1):234-40. PubMed ID: 3100769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
    Wallén NH; Larsson PT; Bröijersén A; Andersson A; Hjemdahl P
    Br J Clin Pharmacol; 1993 Feb; 35(2):143-51. PubMed ID: 8443032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effects of isosorbide dinitrate in man.
    De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
    Z Kardiol; 1983; 72 Suppl 3():46-51. PubMed ID: 6666233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
    Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
    Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
    Kirichenko LL; Gaĭdukova NI; Solov'eva FV
    Sov Med; 1986; (2):91-4. PubMed ID: 3704769
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of platelet function by injectable isosorbide dinitrate.
    De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
    Am J Cardiol; 1984 Jun; 53(11):1683-7. PubMed ID: 6428211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocyte aggregation and fibrinolysis in healthy probands treated with molsidomine, isosorbide-5-mononitrate and placebo].
    Drummer C; Valta-Seufzer U; Spannagl M; Frey A; Lüdke S; Schramm W; Gerzer R
    Z Kardiol; 1991; 80 Suppl 5():43-6. PubMed ID: 1776334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of organic nitrates for activation of guanylate cyclase.
    Schröder H; Noack E
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):235-46. PubMed ID: 2895614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental antithrombotic activity of oral isosorbide dinitrate].
    Plotkine M; Allix M; Guillou J; Boulu R
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():57-60. PubMed ID: 1530431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation.
    Hinz B; Kuntze U; Schröder H
    Biochem Biophys Res Commun; 1998 Dec; 253(3):658-61. PubMed ID: 9918783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.